We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Join our healthcare community
Explore Ocrevus (ocrelizumab) side effects for multiple sclerosis treatment. Learn about common infusion reactions, infections, and serious risks like PML and cancer. Understand when to see a doctor and how to manage side effects effectively.
Ocrevus, with the generic name ocrelizumab, is a prescription medication used to treat adults with relapsing or primary progressive forms of multiple sclerosis (MS). MS is a chronic, autoimmune disease that affects the brain, spinal cord, and optic nerves, leading to a wide range of symptoms.
Ocrevus works by targeting and depleting CD20-positive B cells, a type of white blood cell believed to play a key role in the immune system attacks that damage myelin (the protective sheath around nerve fibers) in MS. While Ocrevus has shown significant efficacy in slowing disease progression and reducing relapse rates, like all medications, it comes with potential side effects. Understanding these side effects is crucial for patients, caregivers, and healthcare providers to manage treatment effectively and ensure patient safety.
This comprehensive guide will delve into the common, serious, and rare side effects associated with Ocrevus, along with guidance on when to seek medical attention, how to manage these effects, and other important considerations for patients undergoing this therapy. While the slug mentions "Zunovo," please note that Ocrevus is the brand name for ocrelizumab, and there is no widely recognized medication called Zunovo in this context. Our discussion will focus solely on Ocrevus (ocrelizumab).
Ocrevus is a monoclonal antibody that selectively targets CD20-positive B cells. These B cells are thought to contribute to the inflammatory and neurodegenerative processes in MS. By depleting these specific B cells, Ocrevus aims to reduce the immune system's attack on the central nervous system, thereby decreasing disease activity and progression.
The medication is administered intravenously (through an IV) by a healthcare professional. The first dose is typically given as two separate infusions two weeks apart, followed by subsequent doses given once every six months. This unique dosing schedule is designed to maintain consistent B-cell depletion while minimizing exposure.
Many patients experience mild to moderate side effects, especially during or shortly after the infusion. It's important to differentiate these from more serious reactions.
Infusion-related reactions are among the most common side effects, occurring particularly with the first few infusions. These reactions typically happen within 24 hours of the infusion and can range from mild to severe. To minimize the risk, patients are usually pre-medicated with a corticosteroid, an antihistamine, and sometimes an antipyretic (like acetaminophen) before each infusion.
Because Ocrevus works by suppressing the immune system, it can increase the risk of infections. This is a common concern with immunosuppressive therapies.
Always report any signs of infection to your doctor, such as fever, chills, persistent cough, or unusual fatigue.
While less common, Ocrevus can cause serious side effects that require immediate medical attention. Being aware of these can help ensure prompt diagnosis and treatment.
Beyond the common infections, Ocrevus can increase the risk of more severe and potentially life-threatening infections.
PML has occurred in patients treated with other MS medications that target B cells. While no cases of PML have been reported in Ocrevus clinical trials, it remains a serious potential risk. Your doctor will monitor you for symptoms of PML and may perform an MRI of your brain.
There is a potential increased risk of certain cancers, particularly breast cancer, in patients treated with Ocrevus. In clinical studies, more cases of breast cancer were reported in patients treated with Ocrevus compared to those treated with interferon beta-1a or placebo.
Patients should undergo routine cancer screenings as recommended by their doctor. Women should continue to receive regular mammograms and breast exams as appropriate for their age and risk factors.
Ocrevus can cause a decrease in immunoglobulin levels (antibodies) in the blood, a condition called hypogammaglobulinemia. Immunoglobulins are crucial for fighting infections. Lower levels can increase the risk of serious and recurrent infections. Your doctor may monitor your immunoglobulin levels during treatment.
Beyond infusion-related reactions, severe allergic reactions (anaphylaxis) can occur, though they are rare. Symptoms include:
Seek emergency medical help immediately if you experience any of these symptoms.
It is crucial to maintain open communication with your healthcare team throughout your treatment with Ocrevus. Contact your doctor immediately if you experience any of the following:
Always discuss any pre-existing medical conditions, allergies, or medications you are taking with your doctor before starting Ocrevus, and report any changes during treatment.
While some side effects are unavoidable, there are strategies to help manage them:
Before starting Ocrevus, your doctor will assess your medical history and discuss potential risks.
Live-attenuated vaccines (e.g., measles, mumps, rubella, varicella, yellow fever) should not be given during Ocrevus treatment or within a specific timeframe before or after treatment, as they could cause severe infection due to your weakened immune system. Your doctor will review your vaccination history and recommend any necessary vaccinations before you start Ocrevus.
Ocrevus may harm an unborn baby. Women of childbearing potential should use effective contraception during treatment and for at least 6 months after the last dose of Ocrevus. It is not known if Ocrevus passes into breast milk, so discussion with your doctor is essential if you are breastfeeding or plan to breastfeed.
Inform your doctor about all medications you are taking, including over-the-counter drugs, supplements, and herbal remedies. Ocrevus can interact with other immunosuppressive or immunomodulating drugs, potentially increasing the risk of infection.
Discuss any history of infections (especially hepatitis B, herpes, or tuberculosis), weakened immune system, cancer, or heart problems with your doctor before starting Ocrevus.
Infusion-related reactions typically occur during or within 24 hours of the infusion and usually resolve within a day or two. Other side effects, like increased susceptibility to infections, can persist throughout the treatment period and potentially for some time after the last dose, as the immune system gradually recovers.
Hair loss is not listed as a common or serious side effect in the official prescribing information for Ocrevus. If you experience hair loss while on Ocrevus, discuss it with your doctor, as it may be related to other factors or conditions.
Weight gain is not directly associated with Ocrevus as a common side effect. However, the pre-medication corticosteroids given before infusions can sometimes cause temporary fluid retention and increased appetite, which might lead to some short-term weight fluctuations. If you are concerned about weight changes, discuss them with your healthcare provider.
Ocrevus works by depleting CD20-positive B cells, which are a part of your immune system. This effect can last for several months after each infusion. Long-term use can lead to sustained reductions in immunoglobulin levels (hypogammaglobulinemia), potentially increasing the risk of recurrent infections. Your doctor will monitor your immune status over time.
It depends on the type of vaccine. Live-attenuated vaccines are generally contraindicated during Ocrevus treatment. Inactivated vaccines (e.g., flu shot, tetanus shot) may be given, but their effectiveness might be reduced due to the immunosuppressive effects of Ocrevus. It's crucial to discuss your vaccination schedule with your neurologist before receiving any vaccine.
Ocrevus (ocrelizumab) represents a significant advancement in the treatment of multiple sclerosis, offering an effective option for managing both relapsing and primary progressive forms of the disease. However, like all powerful medications, it comes with a spectrum of potential side effects, ranging from common infusion-related reactions and increased susceptibility to infections to more serious risks like certain cancers and rare but severe brain infections such as PML.
Patient education and proactive management are paramount. Understanding these potential side effects empowers patients to recognize symptoms early and communicate effectively with their healthcare team. Regular monitoring by your doctor, adherence to pre-medication protocols, and prompt reporting of any concerning symptoms are vital for ensuring the safest possible treatment experience.
Always remember that your healthcare provider is your best resource for personalized information and guidance regarding Ocrevus treatment and its side effects. Never hesitate to voice your concerns or ask questions about your health and medication.
Visit Hospital
Near You
Learn about kidney transplant options in Narendrapur, recovery, and donor criteria. Expert insights for informed decisions.
May 19, 2026
Explore LASIK eye surgery in Madhepura. Learn about eligibility, the procedure, benefits, risks, and costs from trusted specialists.
May 19, 2026
Explore LASIK surgery in Nalanda. Understand eligibility, the procedure, recovery, and costs for vision correction at leading eye clinics.
May 19, 2026